Discontinue cladribine if significant hepatic injury is confirmed, MHRA advises
The Medicines and Healthcare products Regulatory Agency (MHRA) has advised patients to seek urgent medical attention if they develop any clinical features of liver...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc